{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:10:27Z","timestamp":1785168627352,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT102568"],"award-info":[{"award-number":["WT102568"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","award":["HICF-R8-439"],"award-info":[{"award-number":["HICF-R8-439"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.eclinm.2023.101924","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T20:50:42Z","timestamp":1680727842000},"page":"101924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5870-2310","authenticated-orcid":false,"given":"Louise","family":"China","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Tittanegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1401-6930","authenticated-orcid":false,"given":"Dominic","family":"Crocombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiannis","family":"Kallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Freemantle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eclinm.2023.101924_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/apt.13061","article-title":"Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis","volume":"41","author":"Dultz","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.eclinm.2023.101924_bib2","first-page":"R468","article-title":"Use and overuse of proton pump inhibitors in cirrhotic patients","volume":"14","author":"Chavez-Tapia","year":"2008","journal-title":"Med Sci Monit"},{"issue":"46","key":"10.1016\/j.eclinm.2023.101924_bib3","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.3748\/wjg.v16.i46.5869","article-title":"PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis","volume":"16","author":"Garcia-Saenz-de-Sicilia","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101924_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jgh.12065","article-title":"Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis","volume":"28","author":"Deshpande","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.eclinm.2023.101924_bib5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/MEG.0000000000000448","article-title":"Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis","volume":"27","author":"Khan","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101924_bib6","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.4238\/2015.July.3.25","article-title":"Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis","volume":"14","author":"Xu","year":"2015","journal-title":"Genet Mol Res"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101924_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.dld.2015.12.009","article-title":"Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: a meta-analysis","volume":"48","author":"Yu","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"20","key":"10.1016\/j.eclinm.2023.101924_bib8","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.2009.722","article-title":"Acid-suppressive medication use and the risk for hospital-acquired pneumonia","volume":"301","author":"Herzig","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.eclinm.2023.101924_bib9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinternmed.2010.73","article-title":"Proton pump inhibitors and risk for recurrent Clostridium difficile infection","volume":"170","author":"Linsky","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101924_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.30304","article-title":"Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis","volume":"70","author":"Nardelli","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101924_bib11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/hep.28737","article-title":"Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites","volume":"64","author":"Dam","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101924_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2016.09.007","article-title":"Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study","volume":"152","author":"Tsai","year":"2017","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101924_bib13","article-title":"Short-term proton pump inhibitor use and hepatic encephalopathy risk in patients with decompensated cirrhosis","volume":"8","author":"Kuan","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101924_bib14","first-page":"486","article-title":"Bacterial translocation markers in liver cirrhosis","volume":"30","author":"Alexopoulou","year":"2017","journal-title":"Ann Gastroenterol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101924_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101924_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cgh.2011.11.019","article-title":"Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression","volume":"10","author":"Goel","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101924_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1155\/2014\/751921","article-title":"Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites","volume":"28","author":"Ratelle","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101924_bib18","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jhep.2014.11.036","article-title":"Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study","volume":"62","author":"Terg","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.eclinm.2023.101924_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110503","article-title":"Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites","volume":"9","author":"Mandorfer","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101924_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cgh.2014.07.060","article-title":"Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis","volume":"13","author":"O'Leary","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101924_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/hep.28858","article-title":"Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast","volume":"65","author":"Khan","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101924_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.30642","article-title":"Letter to the editor: proton pump inhibitors in cirrhosis: a marker of morbid conditions or a cause of mortality?","volume":"70","author":"Moon","year":"2019","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101924_bib23","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1053\/j.gastro.2016.10.050","article-title":"Proton pump inhibitors and the possible development of hepatic encephalopathy in cirrhotic patients: true association or residual confounding?","volume":"152","author":"Khan","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.eclinm.2023.101924_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A\u00a0randomised trial of albumin infusions in hospitalised patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.eclinm.2023.101924_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023754","article-title":"ATTIRE: albumin to prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial","volume":"8","author":"China","year":"2018","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101924_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"15","key":"10.1016\/j.eclinm.2023.101924_bib27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101924_bib28","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000476","article-title":"Targeted albumin infusions do not improve systemic inflammation or cardiovascular function in decompensated cirrhosis","volume":"13","author":"China","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101924_bib29","article-title":"Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway","volume":"3","author":"Maini","year":"2021","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101924_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"Electronic address eee, European association for the study of the L. EASL clinical practice guidelines on the management of hepatic encephalopathy","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.eclinm.2023.101924_bib31","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/gutjnl-2015-309262","article-title":"U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients","volume":"64","author":"Tripathi","year":"2015","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.eclinm.2023.101924_bib32","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/hep4.1425","article-title":"Incidence of and risk factors for hepatic encephalopathy in a population-based cohort of Americans with cirrhosis","volume":"3","author":"Tapper","year":"2019","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101924_bib33","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/hep.29628","article-title":"A\u00a0risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis","volume":"68","author":"Tapper","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101924_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2015.03.041","article-title":"Proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhosis: an undesirable association?","volume":"63","author":"Miozzo","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101924_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13099-021-00414-8","article-title":"Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis","volume":"13","author":"Alhumaid","year":"2021","journal-title":"Gut Pathog"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101924_bib36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ajg.2012.4","article-title":"Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth","volume":"107","author":"Ratuapli","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101924_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jgh.12667","article-title":"Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis","volume":"30","author":"Garcia-Martinez","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.eclinm.2023.101924_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101716","article-title":"Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: data from the ATTIRE trial","volume":"55","author":"Tittanegro","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101924_bib39","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J\u00a0Hepatol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:15:37Z","timestamp":1762899337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"alternative-id":["S2589537023001013"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101924","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101924"}}